Invion completes clinical trial of INV103 (ALA-CPN10) in lupus patients
19-Aug-2015 -
Invion Limited has completed its Phase II clinical trial entitled “Double-blinded, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics, and biochemical activity of intravenous Cpn10 administration in subjects with SLE (NCT01838694)”.The Company’s ...
clinical trials
lupus erythematosis
phase II studies